
Conference Coverage
10 days ago
Busting ADHD Myths at APSARDLatest Content

A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap

Treating Inflammation to Relieve Depression, Anhedonia

Type C Meeting With FDA Completed for Zervimesine in Dementia With Lewy Bodies

International Holocaust Remembrance Day and Our Long Road Trip

FDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD

Shorts










Digital Edition
Podcasts
Continuing Medical Education
All News

Explore the evolution of social psychiatry, highlighting key achievements and future directions from the World Association of Social Psychiatry's 60th anniversary.

Neurocrine Biosciences launches a phase 2 trial for NBI-1065890.

Sleep is vital for athlete patients, enhancing performance, mental health, and recovery. Discover effective strategies to optimize sleep for peak athletic success.

Explore the complexities of aging, mental health challenges, and the unique opportunities that come with turning 80 in today's society.

LB Pharmaceuticals initiates a phase 2 trial for LB-102, a promising treatment for bipolar depression, aiming to address unmet needs in mood disorders.

What is new in research on major depressive disorder?

Explore how futures thinking empowers mental health professionals to navigate climate change impacts, fostering resilience and agency in uncertain times.

Explore the gradual dangers of societal issues like climate change and mental health, and learn how early intervention can make a difference.


Therapeutic drug monitoring revolutionizes psychiatric care, enhancing treatment precision and patient outcomes through real-time data and personalized medicine strategies.

Explore the concept of interdependence in politics and psychiatry, emphasizing connection and cooperation to enhance mental health and societal well-being.

Government funding cuts to mental health and addiction programs create chaos, prompting swift restoration amid widespread concern from advocacy groups. Read the statement from the AFSP here.

In this CME article, explore the groundbreaking role of muscarinic cholinergic receptors in schizophrenia treatment, highlighting innovative therapies like KarXT for improved patient outcomes.

Artificial intelligence revolutionizes sports, enhancing performance and officiating, while raising concerns about the human element of competition.











































